Want to join the conversation?
$TSS' net revenue rose 12.7%, adjusted EPS rose 22.8% and overall margin grew 178 BP in 1Q16. Consolidated adjusted EBITDA grew 19.3% YoverY. Effective tax rate was 33.6% in the quarter, about 150 BP lower than 1Q15. $TSS ended 1Q16 with 183.4MM common shares outstanding. $TSS completed the acquisition of TransFirst on April 1st.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?